What is the prevalence of Von Willebrand Disease?

TL;DR: Von Willebrand Disease (VWD) is the most common hereditary bleeding disorder, estimated to affect approximately 1% of the general population, though many cases remain asymptomatic or undiagnosed. While clinical prevalence varies significantly based on diagnostic criteria, it is recognized globally as a condition that impacts both males and females equally across all ethnic groups.

Is Von Willebrand Disease considered a rare condition?

While Von Willebrand Disease is categorized as a genetic bleeding disorder, its classification as "rare" is nuanced. Because the mildest forms of Von Willebrand Disease are so prevalent (up to 1 in 100 people), it is often described as common. However, the more severe, symptomatic forms—such as Type 3 Von Willebrand Disease—are significantly rarer, occurring in approximately 1 per million people. The high prevalence of mild cases often leads to the condition being overlooked in medical statistics compared to other, more clinically apparent clotting disorders.

How does gender and age affect the presentation of Von Willebrand Disease?

Unlike X-linked bleeding disorders like Hemophilia, Von Willebrand Disease typically follows an autosomal inheritance pattern, meaning it affects males and females with equal frequency. However, females are more likely to be diagnosed due to the clinical impact of the disease on menstruation and pregnancy. Regarding age of onset, Von Willebrand Disease is a lifelong condition present from birth. Many individuals remain unaware of their status until they encounter a significant hemostatic challenge, such as a major surgery, dental extraction, or, in the case of women, heavy menstrual bleeding (menorrhagia) during adolescence.

What are the challenges in determining accurate prevalence data?

Accurate epidemiological data for Von Willebrand Disease is difficult to establish for several reasons. Many individuals with mild Von Willebrand Disease have levels of von Willebrand factor that fluctuate due to stress, inflammation, or hormonal changes, often falling into a "borderline" range that makes definitive diagnosis challenging. Furthermore, because symptoms can be mild, many people never seek medical attention. Our community at DiseaseMaps.org currently includes 184 people with Von Willebrand Disease who have shared their lived experiences, providing a vital, real-world perspective that complements clinical data by highlighting the diagnostic journey and the often long path to receiving proper care.

Key factors influencing prevalence and diagnosis

• Underdiagnosis: Many mild cases are never identified because individuals do not experience severe bleeding symptoms in daily life.


• Diagnostic Variability: Laboratory testing for Von Willebrand Disease is complex and can be influenced by blood type (O blood group individuals often have naturally lower levels of the protein).


• Geographic Consistency: Unlike some genetic conditions, this disorder does not show significant geographic or ethnic predilection; it is found globally across all populations.


• Symptom Thresholds: Clinical diagnosis is often triggered only when a patient undergoes a procedure that reveals abnormal clotting, rather than through routine screening.

Next steps

• Consult a hematologist specializing in coagulation disorders to interpret blood work accurately.


• Keep a detailed log of bleeding episodes, including duration and triggers, to assist your clinical team.


• Join the DiseaseMaps.org community to connect with others who understand the nuances of living with a bleeding disorder.


• Ensure your medical records clearly state your diagnosis, especially before any planned surgical or dental procedures.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Von Willebrand disease.


• Orphanet: Rare Disease Database (ORPHA:900).


• World Federation of Hemophilia (WFH): Guidelines for the Management of Von Willebrand Disease.


• OMIM (Online Mendelian Inheritance in Man): Von Willebrand Factor (VWF).